Biotricity INC. (BTCY) — 10-Q Filings
All 10-Q filings from Biotricity INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Biotricity's Revenue Jumps 20% Amidst Persistent Going Concern Doubts
— Nov 14, 2025 Risk: high
BIOTRICITY INC. (BTCY) reported a significant increase in revenue for the six months ended September 30, 2025, reaching $7,759,788, up from $6,468,589 in the pr -
Biotricity Narrows Losses on Strong Revenue Growth
— Aug 14, 2025 Risk: high
BIOTRICITY INC. (BTCY) reported a significant increase in revenue for the three months ended June 30, 2025, reaching $3,873,993, up from $3,201,743 in the prior -
BioTricity Inc. Files Q3 2024 10-Q Report
— Feb 19, 2025 Risk: medium
BioTricity Inc. filed its 10-Q for the period ending December 31, 2024, reporting on its financial performance for the third quarter. The company, previously kn -
BioTricity Inc. Files Q2 2025 10-Q
— Nov 14, 2024 Risk: medium
BioTricity Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results for the second quarter and the first six mon -
BioTricity Inc. Files 10-Q for Q2 2024
— Aug 19, 2024 Risk: medium
BioTricity Inc. filed its 10-Q for the period ending June 30, 2024, reporting on its financial performance. The company, formerly known as MetaSolutions, Inc., -
BioTricity Inc. Files 10-Q for Period Ending December 31, 2023
— Feb 20, 2024 Risk: low
BIOTRICITY INC. (BTCY) filed a Quarterly Report (10-Q) with the SEC on February 20, 2024. BioTricity Inc. filed a 10-Q report for the period ending December 31,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX